New Zealand - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingNew Zealand: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024
Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in New Zealand
For the third year in a row, the New Zealand prophylactic medicaments containing insulin market recorded growth in sales value, which increased by X% to $X in 2023. Overall, consumption saw a prominent increase. Prophylactic medicaments containing insulin consumption peaked in 2023 and is likely to continue growth in years to come.
Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Exports from New Zealand
In 2023, shipments abroad of medicaments containing insulin but not antibiotics in measured doses decreased by X% to X kg, falling for the third year in a row after two years of growth. Overall, exports saw a abrupt curtailment. The most prominent rate of growth was recorded in 2013 with an increase of X%. The exports peaked at X tons in 2014; however, from 2015 to 2023, the exports stood at a somewhat lower figure.
In value terms, prophylactic medicaments containing insulin exports reduced rapidly to $X in 2023. In general, exports faced a abrupt contraction. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, the exports hit record highs at $X in 2020; however, from 2021 to 2023, the exports failed to regain momentum.
Exports by Country
Cook Islands (X kg) was the main destination for prophylactic medicaments containing insulin exports from New Zealand, with a approx. X% share of total exports.
From 2012 to 2023, the average annual rate of growth in terms of volume to Cook Islands totaled X%.
In value terms, Cook Islands ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics in measured doses exports from New Zealand.
From 2012 to 2023, the average annual growth rate of value to Cook Islands totaled X%.
Export Prices by Country
In 2023, the average prophylactic medicaments containing insulin export price amounted to $X per ton, with an increase of X% against the previous year. Overall, the export price saw a buoyant increase. The growth pace was the most rapid in 2018 when the average export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2019 to 2023, the average export prices remained at a somewhat lower figure.
As there is only one major export destination, the average price level is determined by prices for Cook Islands.
From 2012 to 2023, the rate of growth in terms of prices for Kiribati amounted to X% per year.
Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses
Imports into New Zealand
In 2023, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported into New Zealand; growing by X% on 2022 figures. In general, imports recorded a buoyant increase. The most prominent rate of growth was recorded in 2022 with an increase of X%. Over the period under review, imports reached the peak figure in 2023 and are expected to retain growth in the near future.
In value terms, prophylactic medicaments containing insulin imports rose sharply to $X in 2023. Overall, imports enjoyed a prominent expansion. The most prominent rate of growth was recorded in 2022 when imports increased by X% against the previous year. Imports peaked in 2023 and are expected to retain growth in the near future.
Imports by Country
In 2023, Australia (X tons) constituted the largest prophylactic medicaments containing insulin supplier to New Zealand, accounting for a X% share of total imports. Moreover, prophylactic medicaments containing insulin imports from Australia exceeded the figures recorded by the second-largest supplier, Brazil (X tons), fourfold. The third position in this ranking was taken by Italy (X tons), with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of volume from Australia totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Brazil (X% per year) and Italy (X% per year).
In value terms, Australia ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics in measured doses to New Zealand, comprising X% of total imports. The second position in the ranking was taken by Brazil ($X), with a X% share of total imports. It was followed by Italy, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value from Australia amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Brazil (X% per year) and Italy (X% per year).
Import Prices by Country
The average prophylactic medicaments containing insulin import price stood at $X per ton in 2023, with an increase of X% against the previous year. Over the last eleven-year period, it increased at an average annual rate of X%. The pace of growth appeared the most rapid in 2013 an increase of X% against the previous year. The import price peaked at $X per ton in 2018; however, from 2019 to 2023, import prices failed to regain momentum.
Average prices varied noticeably amongst the major supplying countries. In 2023, amid the top importers, the highest price was recorded for prices from France ($X per ton) and Brazil ($X per ton), while the price for China ($X per ton) and Denmark ($X per ton) were amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Brazil (X%), while the prices for the other major suppliers experienced mixed trend patterns.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in New Zealand. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
- New Zealand
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in New Zealand
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in Asia.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the U.S..
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in China.
This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in the EU.
This report provides an in-depth analysis of the global market for prophylactic medicaments containing insulin.
- Market Research in New Zealand
- Price for Prophylactic Medicaments Containing Insulin New Zealand
- Prophylactic Medicaments Containing Insulin Market
- Hormones Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Sterile Medical Adhesion Barrier Market